Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ TXNDC5 Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA528520
Description
Recommended positive controls: 293T, HeLa, HepG2, Huh-7. Predicted reactivity: Mouse (83%), Rat (84%), Bovine (85%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
This gene encodes a protein-disulfide isomerase. Its expression is induced by hypoxia and its role may be to protect hypoxic cells from apoptosis. Two transcript variants encoding different isoforms have been found for this gene.
Specifications
TXNDC5 | |
Polyclonal | |
Unconjugated | |
Txndc5 | |
AL022641; ENDOPDI; endoplasmic reticulum protein ERp46; endoplasmic reticulum resident protein 46; endothelial protein disulphide isomerase; ER protein 46; ERp46; FLJ21353; FLJ90810; HCC2; HCC-2; MGC3178; PC-TRP; PDIA15; Plasma cell-specific thioredoxin-related protein; protein disulfide isomerase family A, member 15; STRF8; thiore; thioredoxin domain containing 5; thioredoxin domain containing 5 (endoplasmic reticulum); thioredoxin domain-containing protein 5; thioredoxin related protein; thioredoxin-like protein p46; Tlp46; TXNDC5; UNQ364; UNQ364/PRO700 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
81567 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
1 mg/mL | |
PBS with 1% BSA, 20% glycerol and 0.01% thimerosal; pH 7 | |
Q8NBS9 | |
Txndc5 | |
Recombinant protein encompassing a sequence within the center region of human TXNDC5. The exact sequence is proprietary. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction